Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 77Breast Neoplasms 46Colorectal Neoplasms 42Neoplasms 41Neoplasm Metastasis 34Multiple Myeloma 31Melanoma 31Prostatic Neoplasms 29Stomach Neoplasms 27Recurrence 27Pancreatic Neoplasms 27Lung Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Carcinoma, Renal Cell 25Ovarian Neoplasms 23Lymphoma, Large B-Cell, Diffuse 22Leukemia, Myeloid, Acute 22Triple Negative Breast Neoplasms 21Lymphoma, Non-Hodgkin 21Lymphoma, Follicular 21Leukemia, Lymphocytic, Chronic, B-Cell 19Glioblastoma 19Myelodysplastic Syndromes 17Uterine Cervical Neoplasms 16Lymphoma 16Colonic Neoplasms 15Carcinoma, Transitional Cell 15Lymphoma, Mantle-Cell 14Leukemia 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Active not recruiting × Primary Ovarian Insufficiency × Clear all
NCT05462379 2025-09-05

Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment.

Instituto do Cancer do Estado de São Paulo

Phase 1/2 Active not recruiting
22 enrolled
Gynecologic

Primary Ovarian Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡